Our pregnancy research targets improved screening methods and preventative treatments for mothers and babies.
INFANT’s goal is to develop and test next-generation devices, diagnostics and therapies. These will have a fundamental societal and economic impact, placing Ireland at the fore of pregnancy research.
INFANT is focused on developing and improving methods of monitoring and medical intervention at birth. The reduction or elimination of adverse events in labour (such as hypotension, seizures and pre-eclampsia) will have a direct impact on long-term population health.
We aim to protect mothers and babies by developing innovative medical devices, diagnostics and therapies.
The PARROT study is a randomised control trial which will be a diagnostic aid in the management of pre-eclampsia.
The BEFORE Birth study aims to provide a screening test for pre-term delivery, a leading cause of perinatal mortality.
The IMPROvED study will develop early pregnancy screening tests for pre-eclampsia.
Mothers’ Experiences of Maternal Morbidity.
LEANBH aims to reduce the impact of hypertensive disorders in pregnancy.
The BABYSAFE study is developing non-invasive technology to help assess fetal well-being.
The NEUROPROBE study will develop an innovative method of continuously analysing changes in preterm EEG, NIRS and blood pressure data.
The AI4LIFE project will develop a fetal monitoring system using artificial intelligence to identify oxygen deprivation.
The RE:CURRENT study is evaluating recurrent miscarriage (RM) services in Ireland to inform efforts to standardise and improve the quality of these se…
The CATePILLaR Study is evaluating the impact of COVID-19 restrictions on mother & baby’s health and wellbeing.